Abstract:
The invention relates to a new crystal form of β-cryptoxanthin, processes for its manufacture, liquid formulations comprising such crystal form and processes for the manufacture of such crystal form and its liquid product formulations. Further objects of the present invention are dietary supplements, especially soft capsules and powdered products such as powdered infant formula comprising such liquid formulations of β-cryptoxanthin.
Abstract:
The invention relates to formulations of a new β-cryptoxanthin crystal form, processes for their manufacture and their uses, as well as to products suitable for human consumption comprising such formulations.
Abstract:
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds by using of at least one alkali hydroxide and/or earth alkali hydroxide, to specific formulations and to the use of such specific formulations.
Abstract:
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds, to specific formulations and to the use of such specific formulations.